Key Slides: AASLD Guidance on Evaluating Liver Fibrosis and Inflammation in Hepatitis B Infection

Review key data and AASLD guideline recommendations on methods to evaluate liver fibrosis and inflammation to guide management decisions for patients with HBV infection.
Anna Christina L. dela Cruz, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.27 MB
Released: April 20, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from:
Gilead Sciences, Inc.

Related Content

Download free expert-authored slides to get up-to-date on Asia-Pacific considerations regarding HCC in the setting of hepatitis B.

Grace LH Wong, MD Released: June 10, 2021

Clinical Care Options (CCO) expert Dr Grace LH Wong discusses Asia-Pacific considerations in caring for patients with HBV at risk for HCC

Grace LH Wong, MD Released: June 8, 2021

Expert Clinical Care Options (CCO) commentary on racial disparities in HBV care among Caribbean immigrant communities in the US

Patricia D. Jones, MD, MSCR Released: June 7, 2021

Clinical Care Options (CCO) expert Dr. Norah Terrault on HCC risk scores to inform personalized HCC surveillance in patients with chronic hepatitis B

Norah Terrault Headshot Norah Terrault, MD, MPH Released: June 4, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue